ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Tetrahedron: Asymmetry
Volume 11, Issue 1, 28 January 2000, Pages 53-73
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (4225 K)

Article Toolbox
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/S0957-4166(99)00552-2    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 2000 Elsevier Science Ltd. All rights reserved.

The design, synthesis and biological evaluation of neuraminic acid-based probes of Vibrio cholerae sialidase

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Jennifer C. Wilson, Robin J. Thomson, Jeffrey C. Dyason, Pas Florio, Kaylene J. Quelch, Samia Abo and Mark von ItzsteinCorresponding Author Contact Information, E-mail The Corresponding Author

Department of Medicinal Chemistry, Monash University (Parkville Campus), 381 Royal Parade, Parkville, Victoria 3052, Australia


Received 9 November 1999;
accepted 2 December 1999.
Available online 23 June 2000.

Abstract

A molecular modelling study using the program GRID has been used to investigate the structural requirements of a potential inhibitor binding to Vibrio cholerae sialidase. A number of favourable interactions were predicted between the sialidase and Neu2en derivatives containing hydroxyl- or halogen-substituted acyl groups on the C-5 amine. As a result of this study, a detailed analysis of the interactions of C-5-substituted Neu2en derivatives with the active site of V. cholerae sialidase was undertaken using a conformational searching routine based on molecular dynamics. Based on the results of these molecular design studies several N-acyl-Neu2en-based probes were prepared and evaluated for sialidase inhibition. As envisaged, and pleasingly, the designed compounds were found to be accommodated by the enzyme’s active site architecture, and to be strong inhibitors of V. cholerae sialidase.

Article Outline

1. Introduction
2. Results and discussion
2.1. Molecular modelling
2.1.1. GRID calculations
2.1.1.1. Carboxyl group probe
2.1.1.2. Hydroxyl group probe
2.1.1.3. Halogen probes
2.1.1.4. Nitrogen-based probes
2.1.1.5. Aliphatic/aromatic based probes
2.1.2. Conformational searching routines for C-5-modified Neu5Ac2en derivatives
2.1.2.1. N-Glycolyl-Neu2en 5
2.1.2.2. N-Chloroacetyl-Neu2en 6
2.1.2.3. Aliphatic chain extensions [N-propanoyl- 7, N-butanoyl- 8, and N-(acryloyl)- 9 Neu2en]
2.2. Synthesis of C-5-modified Neu5Ac2en derivatives
2.3. Inhibition of Vibrio cholerae sialidase
2.3.1. N-Glycolyl-Neu2en
2.3.2. N-Haloacetyl-Neu2en derivatives
2.3.3. Effects of altering the aliphatic chain of the N-acyl group
3. Summary
4. Experimental
4.1. Molecular modelling
4.2. Syntheses
4.2.1. 5-Amino-2,6-anhydro-3,5-dideoxy-Image -glycero-Image -galacto-non-2-enoic acid Neu2en 12
4.2.2. 2,6-Anhydro-3,5-dideoxy-5-(2-hydroxyacetamido)-Image -glycero-Image -galacto-non-2-enoic acid [N-glycolyl-Neu2en] 5
4.2.3. 2,6-Anhydro-3,5-dideoxy-5-(2-chloroacetamido)-Image -glycero-Image -galacto-non-2-enoic acid [N-chloroacetyl-Neu2en] 6
4.2.4. 2,6-Anhydro-3,5-dideoxy-5-acrylamido-Image -glycero-Image -galacto-non-2-enoic acid [N-(acryloyl)-Neu2en] 9
4.2.5. 2,6-Anhydro-3,5-dideoxy-5-(2,2,2-trichloroacetamido)-Image -glycero-Image -galacto-non-2-enoic acid [N-trichloroacetyl-Neu2en] 10
4.3. Sialidase assay
Acknowledgements
References










Corresponding Author Contact Information Corresponding author. Fax: +61-3-9903-9672; email: mark.vonitzstein@vcp.monash.edu.au


Tetrahedron: Asymmetry
Volume 11, Issue 1, 28 January 2000, Pages 53-73
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.